Di W - Search Results

1

Retraction Note: Correlation of CD44v6 expression with ovarian cancer progression and recurrence.

Shi J, Zhou Z, Di W, Li N. Shi J, et al. Among authors: di w. BMC Cancer. 2020 Mar 19;20(1):236. doi: 10.1186/s12885-020-06753-0. BMC Cancer. 2020. PMID: 32192432 Free PMC article.

2

[Suppression of insulin-like growth factor-1 receptor by RNA interference inhibits cell growth in vitro and induces chemosensitization of HO8910PM cell to cisplatin].

Gao H, Shi J, Ge SF, DI W. Gao H, et al. Among authors: di w. Zhonghua Fu Chan Ke Za Zhi. 2008 Jan;43(1):45-9. Zhonghua Fu Chan Ke Za Zhi. 2008. PMID: 18366933 Chinese.

3

Effect of hypoxia and re-oxygenation on cell invasion and adhesion in human ovarian carcinoma cells.

Shi J, Wan Y, Di W. Shi J, et al. Among authors: di w. Oncol Rep. 2008 Oct;20(4):803-7. Oncol Rep. 2008. PMID: 18813821

4

The immunologic aspects in advanced ovarian cancer patients treated with paclitaxel and carboplatin chemotherapy.

Wu X, Feng QM, Wang Y, Shi J, Ge HL, Di W. Wu X, et al. Among authors: di w. Cancer Immunol Immunother. 2010 Feb;59(2):279-91. doi: 10.1007/s00262-009-0749-9. Epub 2009 Aug 30. Cancer Immunol Immunother. 2010. PMID: 19727719 Free PMC article. Clinical Trial.

5

Arsenic trioxide and cisplatin synergism increase cytotoxicity in human ovarian cancer cells: therapeutic potential for ovarian cancer.

Zhang N, Wu ZM, McGowan E, Shi J, Hong ZB, Ding CW, Xia P, Di W. Zhang N, et al. Among authors: di w. Cancer Sci. 2009 Dec;100(12):2459-64. doi: 10.1111/j.1349-7006.2009.01340.x. Epub 2009 Sep 2. Cancer Sci. 2009. PMID: 19769630 Free PMC article.

6

[Regulation of microRNA-199a on adhesion, migration and invasion ability of human endometrial stromal cells].

Dai L, Gu LY, Zhu J, Shi J, Wang Y, Ji F, Di W. Dai L, et al. Among authors: di w. Zhonghua Fu Chan Ke Za Zhi. 2011 Nov;46(11):817-21. Zhonghua Fu Chan Ke Za Zhi. 2011. PMID: 22333229 Chinese.

7

Correlation of CD44v6 expression with ovarian cancer progression and recurrence.

Shi J, Zhou Z, Di W, Li N. Shi J, et al. Among authors: di w. BMC Cancer. 2013 Apr 8;13:182. doi: 10.1186/1471-2407-13-182. BMC Cancer. 2013. Retraction in: BMC Cancer. 2020 Mar 19;20(1):236. doi: 10.1186/s12885-020-06753-0 PMID: 23565736 Free PMC article. Retracted.

8

CYR61, a potential biomarker of tumor inflammatory response in epithelial ovarian cancer microenvironment of tumor progress.

Shi J, Huo R, Li N, Li H, Zhai T, Li H, Shen B, Ye J, Fu R, Di W. Shi J, et al. Among authors: di w. BMC Cancer. 2019 Nov 25;19(1):1140. doi: 10.1186/s12885-019-6321-x. BMC Cancer. 2019. PMID: 31766991 Free PMC article.

9

Long-term follow-up of 46 cases of primary fallopian tube carcinoma: a single institute study.

Li S, Yu M, Bai W, Shi J, Di W. Li S, et al. Among authors: di w. Ann Palliat Med. 2021 Aug;10(8):9122-9135. doi: 10.21037/apm-21-2083. Ann Palliat Med. 2021. PMID: 34488398 Free article.

10

Correlation between CD44 and membrane fluidity-a study on biopsies of high-grade serous ovarian tumor.

Shi J, Yang Y, He W, Moses M, Gu YH, Li N, Di W. Shi J, et al. Among authors: di w. Acta Biochim Biophys Sin (Shanghai). 2022 Dec 25;54(12):1928-1930. doi: 10.3724/abbs.2022190. Acta Biochim Biophys Sin (Shanghai). 2022. PMID: 36789687 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

683 results

Search Page

Filters